ArticleClinical kidney journal2026
Changing prognostic significance of peritoneal transport status in contemporary incident peritoneal dialysis patients.
Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High peritoneal transport status has traditionally been linked to adverse outcomes in peritoneal dialysis (PD). However, its clinical relevance in contemporary, individualized PD practice remains unclear. We therefore evaluated its association with long-term outcomes across three successive treatment eras. Methods: We conducted a retrospective cohort study of 473 incident PD patients treated between 2000 and 2024, grouped into three treatment eras reflecting major changes in PD practice. Baseline peritoneal transport status was defined by the 4-h dialysate-to-plasma creatinine ratio and categorized as high or non-high. The primary outcome was technique failure. Fine-Gray competing-risk models were used to assess technique failure and all-cause mortality, including transport-by-era interaction terms. Results: Of these, 114 (24.1%) were classified as high transporters. In the earliest era, high transport status was associated with nearly two-fold higher crude technique failure rates than non-high status, but this difference narrowed over time and was minimal in the most recent era. In fully adjusted competing-risk models, high transport status was not independently associated with technique failure; instead, more recent treatment era and higher serum albumin were associated with a lower risk of technique failure. A significant transport-by-era interaction suggested attenuation of the adverse prognostic impact of high transport status in contemporary practice ( Conclusion: The prognostic significance of high peritoneal transport status appears to be era-dependent and less pronounced in contemporary PD practice. These findings suggest that PET-derived transport status may be better interpreted as a guide for individualized PD prescription rather than as a fixed predictor of adverse outcome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.